Cite
HARVARD Citation
Edlund, H. et al. (2022). Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP‐5862, in patients with B‐cell malignancies and in healthy subjects using a population pharmacokinetic approach. British journal of clinical pharmacology. 88 (2), pp. 846-852. [Online].